These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36467597)

  • 1. Short-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study.
    Chambers J; Malhi G; Mikail M; Khanna R; Wilson A
    J Can Assoc Gastroenterol; 2022 Dec; 5(6):251-255. PubMed ID: 36467597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic.
    Malhi G; Minhas G; Chambers J; Mikail M; Khanna R; Wilson A
    J Can Assoc Gastroenterol; 2022 Dec; 5(6):271-275. PubMed ID: 36467602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
    Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The trends and outcomes of inflammatory bowel disease surgery during the COVID-19 pandemic: A retrospective propensity score-matched analysis from a multi-institutional research network.
    Wu F; Ibarburu GH; Grimes C
    Health Sci Rep; 2024 Oct; 7(10):e70107. PubMed ID: 39355102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
    Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice.
    Chen Y; Yu Q; Farraye FA; Kochhar GS; Bernstein CN; Navaneethan U; Wu K; Zhong J; Schwartz DA; Wu H; Zheng JJ; Iacucci M; Kiran RP; Shen B
    Intest Res; 2021 Jul; 19(3):332-340. PubMed ID: 32475088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.
    Hong SJ; Bhattacharya S; Aboubakr A; Nadkarni D; Lech D; Ungaro RC; Agrawal M; Hirten RP; Greywoode R; Mone A; Chang S; Hudesman DP; Ullman T; Sultan K; Lukin DJ; Colombel JF; Axelrad JE
    Therap Adv Gastroenterol; 2022; 15():17562848221132363. PubMed ID: 36348637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease.
    Ko MS; Rudrapatna VA; Avila P; Mahadevan U
    Dig Dis Sci; 2020 Oct; 65(10):2979-2985. PubMed ID: 32034603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe adverse outcomes of endoscopic perforations in patients with and without IBD.
    Mukewar S; Costedio M; Wu X; Bajaj N; Lopez R; Brzezinski A; Shen B
    Inflamm Bowel Dis; 2014 Nov; 20(11):2056-66. PubMed ID: 25265263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.
    Deputy M; Sahnan K; Worley G; Patel K; Balinskaite V; Bottle A; Aylin P; Burns EM; Hart A; Faiz O
    Aliment Pharmacol Ther; 2022 Apr; 55(7):836-846. PubMed ID: 35132663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease.
    Wetwittayakhlang P; Albader F; Golovics PA; Hahn GD; Bessissow T; Bitton A; Afif W; Wild G; Lakatos PL
    Can J Gastroenterol Hepatol; 2021; 2021():7591141. PubMed ID: 34858891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
    Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
    Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of COVID-19 in Patients with Inflammatory Bowel Disease: Comparison with Household Members and the Role of IBD Medications.
    Sima AR; Saberzadeh-Ardestani B; Vahedi H; Fakheri H; Mansour-Ghanaei F; Maleki I; Nasseri-Moghaddam S; Vosoghinia H; Ghadir MR; Hormati A; Kasaeian A; Radmard AR; Khosravi B; Malekzadeh M; Alatab S; Sadeghi A; Aminisani N; Poustchi H; Gonoudi E; Anushiravani A; Rayatpisheh M; Colombel JF; Ungaro RC; Malekzadeh R
    Arch Iran Med; 2022 Jan; 25(1):17-25. PubMed ID: 35128908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
    Iacucci M; Cannatelli R; Labarile N; Mao R; Panaccione R; Danese S; Kochhar GS; Ghosh S; Shen B
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):598-606. PubMed ID: 32305075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: the care must go on.
    Casper M; Reichert MC; Rissland J; Smola S; Lammert F; Krawczyk M
    Eur J Med Res; 2022 Mar; 27(1):41. PubMed ID: 35303954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of inflammatory bowel disease in the COVID-19 era.
    Kim KO; Jang BI
    Intest Res; 2022 Jan; 20(1):3-10. PubMed ID: 33525860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 on diagnosis and management of paediatric inflammatory bowel disease during lockdown: a UK nationwide study.
    Ashton JJ; Kammermeier J; Spray C; Russell RK; Hansen R; Howarth LJ; Torrente F; Deb P; Renji E; Muhammed R; Paul T; Kiparissi F; Epstein J; Lawson M; Hope B; Zamvar V; Narula P; Kadir A; Devadason D; Bhavsar H; Beattie RM
    Arch Dis Child; 2020 Dec; 105(12):1186-1191. PubMed ID: 32732316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.